WHO Members Delve Into Draft 5-Year Work Programme, Question Finance, Focus 22/11/2017 by Catherine Saez, Intellectual Property Watch 2 Comments World Health Organization member states’ first reactions to the secretariat-proposed draft work programme for the next five years were mixed this morning. Although many praised the effort and the vision of the programme of work, in particular its alignment with the United Nations Sustainable Development Goals, a number of countries found the programme ambitious without the needed financial backing, and sometimes straying from the core function of the organisation.
WHO Draft Work Program To Be Presented, Discussed 21/11/2017 by Intellectual Property Watch Leave a Comment The World Health Organization is presenting its draft work program for 2019-2023 for consideration by member states this week.
First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information.
South Centre: Clear Rules Needed On Biosimilars Equivalence To Help Market Entry, Lower Prices 09/11/2017 by Intellectual Property Watch Leave a Comment As soon as 2022, biological drugs made from active protein substances are expected to make up 50 percent of the pharmaceutical market, as they are increasingly used to treat a number of illnesses such as diabetes, cancer and hepatitis. But with the high price of therapeutics and difficulty in producing biologically similar products, and with the originator products now coming off patent, regulation is of high importance, says a new report from the intergovernmental South Centre.
WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals.
Hepatitis C Buyers’ Clubs Grow Worldwide As A Way To Obtain Affordable Treatment 07/11/2017 by Tatum Anderson for Intellectual Property Watch Leave a Comment Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million worldwide and kills around 400,000 people a year. But importantly, these groups of patients from Russia to Australia have got together to help each other import a relatively new class of drug that is able to cure most of the patients who take it.
New WHO 5-Year Programme Is Out. In The Recipe? SDGs, Access To Medicines, Innovation, Better Health For All 01/11/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The new leadership of the World Health Organization today issued its draft new programme of work for the next five years. The programme depicts new orientations for the global health actor, starting with the alignment of the programme with the United Nations Sustainable Development Goals and universal health coverage. The organisation also commits to help establish policies promoting access to health products, including generic medicines, innovation, and fair pricing. The WHO is set to help address innovation barriers, and to step up its global leadership, but asks that its members actually fully finance the budget that they approve.
MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug 31/10/2017 by Intellectual Property Watch 1 Comment Médecins Sans Frontières (MSF, Doctors Without Borders) announced today that it has secured deals for two key generic hepatitis C medicines, dropping prices dramatically.
WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 by Catherine Saez, Intellectual Property Watch 1 Comment After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines.
Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system.